260 related articles for article (PubMed ID: 21672483)
1. Recent developments in kidney cancer.
Leveridge MJ; Jewett MA
Can Urol Assoc J; 2011 Jun; 5(3):195-203. PubMed ID: 21672483
[TBL] [Abstract][Full Text] [Related]
2. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
[TBL] [Abstract][Full Text] [Related]
3. Use of surveillance imaging following treatment of small renal masses.
Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.
MacLennan S; Imamura M; Lapitan MC; Omar MI; Lam TB; Hilvano-Cabungcal AM; Royle P; Stewart F; MacLennan G; MacLennan SJ; Dahm P; Canfield SE; McClinton S; Griffiths TR; Ljungberg B; N'Dow J; ;
Eur Urol; 2012 Dec; 62(6):1097-117. PubMed ID: 22841673
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007.
Kowalczyk KJ; Choueiri TK; Hevelone ND; Trinh QD; Lipsitz SR; Nguyen PL; Lynch JH; Hu JC
BJU Int; 2013 Aug; 112(4):E273-80. PubMed ID: 23452093
[TBL] [Abstract][Full Text] [Related]
6. Treating the two extremes in renal cell carcinoma: management of small renal masses and cytoreductive nephrectomy in metastatic disease.
Kim DY; Wood CG; Karam JA
Am Soc Clin Oncol Educ Book; 2014; ():e214-21. PubMed ID: 24857105
[TBL] [Abstract][Full Text] [Related]
7. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
Patel HD; Pierorazio PM; Johnson MH; Sharma R; Iyoha E; Allaf ME; Bass EB; Sozio SM
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1057-1069. PubMed ID: 28483780
[TBL] [Abstract][Full Text] [Related]
8. Treatment of localised renal cell carcinoma.
Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
[TBL] [Abstract][Full Text] [Related]
9. Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort.
Carbonara U; Simone G; Minervini A; Sundaram CP; Larcher A; Lee J; Checcucci E; Fiori C; Patel D; Meagher M; Crocerossa F; Veccia A; Hampton LJ; Ditonno P; Battaglia M; Brassetti A; Bove A; Mari A; Campi R; Carini M; Sulek J; Montorsi F; Capitanio U; Eun D; Porpiglia F; Derweesh I; Autorino R
Eur Urol Focus; 2021 Sep; 7(5):1115-1120. PubMed ID: 33153954
[TBL] [Abstract][Full Text] [Related]
10. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.
Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA
J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224
[No Abstract] [Full Text] [Related]
11. Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.
Young S; Golzarian J; Anderson JK
Semin Intervent Radiol; 2019 Dec; 36(5):367-373. PubMed ID: 31798209
[TBL] [Abstract][Full Text] [Related]
12. Can ablation win against partial nephrectomy and become first line therapy in cT1a renal tumours?
Sandbergen L; Guven S; Laguna MP
Curr Opin Urol; 2019 Jan; 29(1):70-77. PubMed ID: 30308573
[TBL] [Abstract][Full Text] [Related]
13. Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.
Pierorazio PM; Johnson MH; Patel HD; Sozio SM; Sharma R; Iyoha E; Bass EB; Allaf ME
J Urol; 2016 Oct; 196(4):989-99. PubMed ID: 27157369
[TBL] [Abstract][Full Text] [Related]
14. Management of Small Renal Masses.
Chenam A; Lau C
Cancer Treat Res; 2018; 175():105-126. PubMed ID: 30168119
[TBL] [Abstract][Full Text] [Related]
15. Active Surveillance in Small Renal Masses in the Elderly: A Literature Review.
Cheung DC; Finelli A
Eur Urol Focus; 2017 Oct; 3(4-5):340-351. PubMed ID: 29175368
[TBL] [Abstract][Full Text] [Related]
16. The role of open radical nephrectomy in contemporary management of renal cell carcinoma.
Kalapara AA; Frydenberg M
Transl Androl Urol; 2020 Dec; 9(6):3123-3139. PubMed ID: 33457285
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A Review.
Ghoreifi A; Vaishampayan U; Yin M; Psutka SP; Djaladat H
JAMA Oncol; 2024 Feb; 10(2):240-248. PubMed ID: 38095885
[TBL] [Abstract][Full Text] [Related]
19. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.
Salagierski M; Wojciechowska A; Zając K; Klatte T; Thompson RH; Cadeddu JA; Kaouk J; Autorino R; Ahrar K; Capitanio U;
Eur Urol Oncol; 2018 Oct; 1(5):395-402. PubMed ID: 31158078
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
